| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/06/2006 | EP1697511A2 Immunotherapy compositions, method of making and method of use thereof |
| 09/06/2006 | EP1697509A1 Processing of peptides and proteins |
| 09/06/2006 | EP1697418A2 Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation |
| 09/06/2006 | EP1697411A1 Process for purifying interferon beta |
| 09/06/2006 | EP1696944A2 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 09/06/2006 | EP1696864A2 Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins |
| 09/06/2006 | EP1563075A4 Plasmids expressing human insulin and the preparation method for human insuling thereby |
| 09/06/2006 | EP1328643B1 FERMENTATIVE PRODUCTION OF D-p-HYDROXYPHENYLGLYCINE AND D-PHENYLGLYCINE |
| 09/06/2006 | EP1322383B9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 09/06/2006 | EP1124992A4 Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns |
| 09/06/2006 | EP1088075B1 Aav structural protein, production and use thereof |
| 09/06/2006 | EP1055726B1 Candida boidinii dihydroxyacetone synthase promoter |
| 09/06/2006 | EP0955366B1 Antigenic protein originating in malassezia |
| 09/06/2006 | EP0832232B9 Kunitz type plasma kallikrein inhibitors |
| 09/06/2006 | EP0789762B1 Methods for the diagnosis of glaucoma |
| 09/06/2006 | EP0760857B9 Receptor for oncostatin m |
| 09/06/2006 | CN1829798A Protease, DNA coding for the protease and process for producing the protease |
| 09/06/2006 | CN1829533A Antibodies and fusion proteins that include engineered constant regions |
| 09/06/2006 | CN1827773A Process for preparing bacteriostatic peptide by discarded tobacco leaf protein |
| 09/06/2006 | CN1827772A Soybean peptide production method |
| 09/06/2006 | CN1827769A Constructing method for transgene Chlamydomonas reinhardtii bioreactor |
| 09/06/2006 | CN1827648A Phi C31 integrase polyclonal antibody and its use |
| 09/06/2006 | CN1827646A Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/06/2006 | CN1827640A Polypeptide for inhibition of angiogenesis and method for preparing same and use thereof |
| 09/06/2006 | CN1827633A Process for extracting N6-(2-ethoxyl) adenosine from Paecilomyces Cicadae Samson culture |
| 09/06/2006 | CN1827168A Treatment of t cell mediated autoimmune disorders |
| 09/06/2006 | CN1827167A Animal medicine capable of increasing immunologic function of livestock and birds |
| 09/06/2006 | CN1827165A Animal medicine capable of increasing weight of meat chicken |
| 09/06/2006 | CN1827164A Animal medicine capable of rehabilitating intestinal tract injury |
| 09/06/2006 | CN1827163A Technique for preparing animal medicine with immunity-improving function |
| 09/06/2006 | CN1827162A Animal medicine capable of resisting multiple irritated stress of chicken |
| 09/06/2006 | CN1273605C 蛋白质生产系统 Protein Production System |
| 09/06/2006 | CN1273598C Bactericidal/permeability-increasing protein delation analogs |
| 09/06/2006 | CN1273586C Novel 'beta'-l-4N-acetylglucosaminyltransferase and gene encoding the same |
| 09/06/2006 | CN1273485C Immunoglobulin sample receptor originated from human dendritic cell, its coding sequence and application |
| 09/05/2006 | USRE39270 infecting insect larvae with a baculovirus vector of a DNA encoding the protein of interest linked to a gene encoding a green fluorescent protein; fusion protein is expressed; measuring GFT fluorescence |
| 09/05/2006 | US7102059 Isolated nucleic acid molecule containing one open reading frame; a nucleotide sequence, or a complementary sequence encoding proteins or polypeptides of Pseudomonas CEL and EEL genomic regions or hybridizes to a DNA molecule |
| 09/05/2006 | US7101992 Nucleic acid base pair |
| 09/05/2006 | US7101989 Isolated polynucleotides of DNA, a polynucleotide that hybridizes to the DNA, or a polynucleotide that encodes a full length DsrA. |
| 09/05/2006 | US7101988 Polyvalent cation-sensing receptor in Atlantic salmon |
| 09/05/2006 | US7101985 Methods and compositions in checkpoint signaling |
| 09/05/2006 | US7101984 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/05/2006 | US7101980 Derivatives, conjugates, and antibodies for detecting ecstasy-class analytes |
| 09/05/2006 | US7101979 Antibodies to antiangiogenic compositions and methods |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101976 Targeting the extracellular domain of EphA2 and operating to redirect the function of EphA2 to selectively block the growth and invasiveness of metastatic cells |
| 09/05/2006 | US7101974 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 09/05/2006 | US7101971 Erythropoietin analog-human serum albumin fusion |
| 09/05/2006 | US7101962 Antibodies of the P2Y10 receptor useful in altering T lymphocyte function |
| 09/05/2006 | US7101850 WISP polypeptides and nucleic acids encoding same |
| 09/05/2006 | US7101849 ωconotoxin peptides |
| 09/05/2006 | US7101714 Nucleotide sequences coding polypeptide for us e in the diagnosis, prevention and treatment of inflammatory defects |
| 09/05/2006 | US7101700 Peptide vector |
| 09/05/2006 | US7101699 Comprises enzymatic polypeptide for treatment and prevention of neurodegenerative and cell proliferative disorders; wound healing agents |
| 09/05/2006 | US7101698 Comprises proteolytic enzymes for use in detergents and laundering |
| 09/05/2006 | US7101696 Polyhydroxyalkanoate synthase and gene encoding the same enzyme |
| 09/05/2006 | US7101689 Interleukin-18 binding proteins, their preparation and use |
| 09/05/2006 | US7101686 Polynucleotides encoding human SLAP-2:a novel SH2/SH3 domain-containing human SLAP homologue having immune cell-specific expression |
| 09/05/2006 | US7101683 Hepatitis C virus (HCV) proteins; chemiluminescence; genetic engineering |
| 09/05/2006 | US7101680 Method for detecting the presence of monomeric brain associated human glutamine synthetase |
| 09/05/2006 | US7101678 Method for detecting or quantifying basophils and eosinophils |
| 09/05/2006 | US7101675 Modulators of regulatory proteins |
| 09/05/2006 | US7101662 Generating nonradioactive marker for use in genetic analysis; obtain adjusted adaptor nucleotide sequences, incubate with target sequences, translated and recover protein |
| 09/05/2006 | US7101555 Microorganismal polypeptides for use in diagnosis and treatment of respiratory system disorders; genetic vaccines |
| 09/05/2006 | US7101551 Substance which inhibits binding between E2/NS1 protein of hepatitis C virus and cell infectious with hepatitis C virus, a cell expressing CD81, or CD81 |
| 09/05/2006 | US7101549 nucleic acid molecules and polypeptide molecules that encode glycoprotein VI; modulating agents in regulating a variety of cellular processes |
| 09/05/2006 | US7101542 Cell-mediated targeting of toxins to pathogenic cells |
| 09/05/2006 | CA2143642C Immunoreactive peptides from epstein-barr virus |
| 09/03/2006 | WO2006096164A1 Media for clostridium bacterium and processes for obtaining a clostridial toxin |
| 09/03/2006 | WO2006096163A1 Animal product free system and process for purifying a botulinum toxin |
| 09/03/2006 | CA2556796A1 Animal product free system and process for purifying a botulinum toxin |
| 09/03/2006 | CA2556537A1 Media for clostridium bacterium and processes for obtaining a clostridial toxin |
| 08/31/2006 | WO2006091892A2 Methods of producing recombinant proteins |
| 08/31/2006 | WO2006091871A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 08/31/2006 | WO2006091638A2 Circular permutant gfp insertion folding reporters |
| 08/31/2006 | WO2006091483A1 Phage-derived vectors and methods for protein expression |
| 08/31/2006 | WO2006091231A2 Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| 08/31/2006 | WO2006089921A1 Blood pressure lowering peptides from glycomacropeptide |
| 08/31/2006 | WO2006074914A3 Human rna helicase and therapeutic uses thereof |
| 08/31/2006 | WO2006073892A3 Phi 15 dna polymerase |
| 08/31/2006 | WO2006066595A3 Recombinant production of serum albumin |
| 08/31/2006 | WO2006065975A3 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
| 08/31/2006 | WO2006056700A3 Biomaterial which can successively carry out a solution/gel transition then a gel/solution transition |
| 08/31/2006 | WO2006023403A3 Eph receptor fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 08/31/2006 | US20060195947 Variant polypeptides having enhanced ketoreductase activity and/or thermostability for use in the stereospecific reduction of ketones; non-naturally occurring ketoreductas polypeptide capable of converting ethyl 4-chloroacetoacetate to ethyl (S)-4-chloro-3-hydroxybutyrate |
| 08/31/2006 | US20060195945 Method for preparing fusion polypeptide comprising epidermal growth factor and human serum albumin in plants |
| 08/31/2006 | US20060195939 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
| 08/31/2006 | US20060195938 Polynucleotides encoding insect acetyl coenzyme-A carboxylase and uses thereof |
| 08/31/2006 | US20060194956 Method for generating antibodies |
| 08/31/2006 | US20060194954 Immunoadhesin protein for use as tools in targeting preferential cells for destruction |
| 08/31/2006 | US20060194951 Polynucleotides encoding interferon gamma polypeptides |
| 08/31/2006 | US20060194950 separating antibodies from proteases; provide a mutated immunoglobulin-binding protein ligand that exhibits an improved stability at increased pH-values, and accordingly an improved tolerance to cleaning under alkaline conditions |
| 08/31/2006 | US20060194735 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 08/31/2006 | US20060194714 Novel depsipeptides and process for preparing same |
| 08/31/2006 | US20060194340 Also, utilization of mass spectrometry (e.g., Surface Enhanced Laser Desorption Ionization, Maldi Qq TOF, MS/MS, TOF TOF, ESI-Q-TOF or ION-TRAP) to elucidate particular indicative or predictive biopolymer markers |
| 08/31/2006 | US20060194339 Isolated biopolymer marker peptide; using mass spectrometry to determine markers predictive of insulin resistance |
| 08/31/2006 | US20060194338 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 08/31/2006 | US20060194337 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 08/31/2006 | US20060194328 Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins |
| 08/31/2006 | US20060194314 Novel Bt toxin receptors from lepidopteran insects and methods of use |